<DOC>
	<DOC>NCT02547701</DOC>
	<brief_summary>Pediatric patients affected by mild-to-moderate distal subungual onychomycosis (DSO) or affected by white superficial onychomycosis (WSO), due to dermatophytes, will be treated topically with P-3058 nail solution according to the appropriate treatment schedule.</brief_summary>
	<brief_title>Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Age between 2 to 17 years Males and females Clinical diagnosis of mildtomoderate distal subungual onychomycosis without spikes/dermatophytoma and without lunula involvement or white superficial onychomycosis. Positive mycroscopy examination from the target nail at screening. Positive culture for dermatophyte from the target nail at screening. Patients with onychomycosis caused by yeasts or nondermatophytes mould. Patients with nail psoriasis. Patients with nail changes due to eczema, lichen planus or alopecia areata. Patients with onehand twofoot syndrome. Patients with immunodeficiency disorder or use of immune suppressive therapy 3 months prior to screening visit or need for it. Use of systemic antifungal drugs in the 6 months prior to screening visit. Use of topical nail antifungal drugs in the four weeks prior to screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>